Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer.

By W. Breitbart, Barry Rosenfeld, H. Pessin, Monique Kaim, Julie Funesti-Esch, Michele M Galietta, C. Nelson, R. Brescia. Journal of the American Medical Association (JAMA), 2000

1,031 citations recorded by the source corpus.

Subfields: Clinical Psychology, Oncology, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/4c1089b46665c27b78470aa543942c30c221afd9

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Clinical Psychology

1. Richard P. Moser
2. J. Wittkowski
3. E. Bromet
4. Ronald C. Kessler
5. R. Neimeyer
6. Crystal L. Park
7. J. Gillies
8. D. Larson

In Public Health, Environmental and Occupational Health

1. E. Bromet
2. H. Chochinov
3. Ronald C. Kessler
4. R. Neimeyer
5. A. Mitchell
6. N. Sampson

Citations in the corpus

• Brain–computer interfaces: communication and restoration of movement in paralysis (2007, background): “In studies by Breitbart et al. (2000) and at the University of Tuebingen by Kübler et al.”
• Dignity-conserving care--a new model for palliative care: helping the patient feel valued. (2002, background): “Hopefulness is seeing life as enduring, or as having sustained meaning or purpose.(37,38) Autonomy/control is the ability to maintain a sense of control over one’s life circumstances.”
• Assessing Attitudes Toward Dying and Death: Psychometric Considerations (2003, methodology): “It has also been used in theoretically meaningful research, with one study demonstrating that depression and hopelessness were significant predictors of a desire for hastened death independent of social support and physical functioning (Breitbart et al., 2000).”
• Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial (2016, background): “With a growing body of evidence linking higher levels of existential/spiritual wellbeing (in cancer patients) with improved quality of life and decreased depression/hopelessness/suicidality (Breitbart et al., 2000; McClain et al., 2003; Nelson et al., 2002), the need to develop effective therapeutic”
• The Vital Link Between Chronic Disease and Depressive Disorders (2004, background): “Depression assumes particular significance in the care of individuals with cancer, because it has been associated with a desire for hastened death among terminally ill cancer patients (64), and increased depressive symptoms are inversely related to survival (65).”
• Breaking the silence: brain-computer interfaces (BCI) for communication and motor control. (2006, background): “In studies by Breitbart , Rosenfeld , and Penin ( 2000 ) and by our group ( Ku¨bler , Winter , et al .”
• Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. (2011, background): “%) had been recently diagnosed and were being assessed for cancer staging and initial cancer treatment; the remaining 18% were undergoing a recurrence assessment Gynaecological 100 USA Grandi et al (1987)66 0 1 0 18 53 Breast DSM-III criteria Stage II or III Breast 100 Italy Grassi et al (1993)67 0 ”
• The epidemiology of depression across cultures (2013, background): “A number of reasons could be involved here, but one of the most consistently documented is that depression is often associated with non-adherence to treatment regimens (12, 24, 146).”